Chapter 64: Managing Neurologic Infections & Autoimmune Disorders

Managing Neurologic Infections & Autoimmune Disorders nursing chapter focuses on the specialized management, pathophysiology, and treatment strategies for patients experiencing diverse neurologic infections, autoimmune processes, and specific cranial and peripheral neuropathies. The section on infectious disorders begins with meningitis, detailing the acute inflammation of the protective meninges, differentiating between septic (bacterial, often Streptococcus pneumoniae or Neisseria meningitidis) and aseptic (viral) types, and outlining hallmark symptoms like nuchal rigidity (stiff neck), severe headache, positive Kernig and Brudzinski signs, and the critical risk of increased intracranial pressure (ICP). Treatment emphasizes prompt antibiotic administration, potentially adjunct corticosteroids, and crucial infection control measures. Also covered are brain abscesses, localized collections of infectious material within the brain tissue often originating from ear or sinus infections, presenting with characteristic morning headaches and focal neurologic deficits, requiring drainage and targeted antimicrobial therapy. Encephalitis, acute brain tissue inflammation, is reviewed, highlighting the herpes simplex virus (HSV) as the primary U.S. cause, treated effectively with acyclovir, alongside seasonal arthropod-borne viruses, which necessitate supportive care and public prevention education to mitigate mosquito exposure. The chapter addresses transmissible spongiform encephalopathies (TSEs) like Creutzfeldt-Jakob disease (CJD), emphasizing their progressive, fatal course caused by prions (a unique pathogen resistant to standard sterilization procedures) and the necessity of strictly supportive, palliative care and specialized sterilization protocols to prevent transmission. The content then shifts to major autoimmune neurologic disorders. Multiple Sclerosis (MS) is explored as a progressive, immune-mediated central nervous system (CNS) demyelination disorder resulting in varied symptoms like debilitating fatigue, spasticity, diplopia (double vision), and cognitive impairment. Management aims to delay progression and manage symptoms using disease-modifying agents, alongside comprehensive nursing interventions focused on promoting physical mobility, avoiding falls, managing fatigue, and strengthening coping mechanisms. Myasthenia Gravis (MG), an impairment of the myoneural junction due to antibodies blocking acetylcholine receptor sites, causes voluntary muscle weakness, especially in ocular (ptosis, diplopia) and bulbar (dysphagia, dysphonia) muscles. Diagnosis can be confirmed using the acetylcholinesterase inhibitor test. Treatment involves anticholinesterase medications, immunosuppression, therapeutic plasma exchange, and thymectomy. A critical complication is myasthenic crisis, which mandates immediate respiratory support. Finally, Guillain-Barré Syndrome (GBS), an acute autoimmune peripheral nerve demyelination often following viral infection, manifests as characteristic ascending weakness (starting in the lower extremities and progressing upward). GBS is a medical emergency requiring rigorous respiratory monitoring and interventions like intravenous immune globulin (IVIG) or therapeutic plasma exchange to reduce circulating antibody levels. The chapter concludes with discussions on cranial neuropathies, including trigeminal neuralgia (CN V), characterized by severe, unilateral shooting facial pain triggered by minimal stimulation (managed primarily with anticonvulsants), and Bell’s palsy (CN VII), causing temporary unilateral facial paralysis, where corticosteroids and crucial eye protection are essential components of care. Throughout the management of all these complex conditions, the nursing process serves as a framework, stressing detailed neurologic assessment, patient education, emotional support, and long-term rehabilitation.